30
nanotimes
Companies
Facts
N
anometrics Incorporated (NASDAQ: NANO), a leading supplier of advanced process control
metrology systems used primarily in the manufactu- ring and packaging of semiconductors, solar photo- voltaics and high-brightness LEDs, announced that additional UniFire™ 7900 metrology systems have been delivered and qualified by an existing custo- mer, and are currently in production for high volume manufacturing process control of advanced wafer- level packaging processes. This multi-system follow- on installation is part of an ongoing program to deploy Nanometrics’ UniFire technology across mul- tiple manufacturing sites. The systems are being used to measure critical dimensions (CD), topography and overlay registration at the 32nm node for die prepa- ration applications.
http://www.nanometrics.com
n
anoMR Inc. received another $2.5 million in venture capital in January to conduct clinical tri-
als on a device to rapidly diagnose bacteria in blood. To date, nanoMR has received $8 million in funding and recently started its first clinical study. nanoMR has developed a proprietary detection technology based on miniaturized nuclear magnetic resonance.
New Mexico Business Weekly, April 23, 2010
http://www.nanomr.com
N
ano Retina has received a grant for just under three-quarters of one million dollars from the
Israel-U.S. Binational Industrial Research and Deve- lopment (BIRD) Foundation. The financing will be used to further develop the Bio-Retina, a “bionic retina” designed to return full sight to those blinded by retinal degenerative conditions. Bio-Retina is a tiny implant designed to replace the damaged retina in the eye. The implant‘s nano-sized components are
powered by a special pair of activation eyeglasses. Bio-Retina will be surgically implanted in a minimally invasive, 30-minute procedure, which requires only local anesthesia. Full sight is anticipated instantane- ously.
“50,000 people in the United States become blind annually. In addition, there are currently 3.6 million Americans aged 40 and older who are legally blind. Bio-Retina is designed to restore full sight to those blinded by degenerative conditions such as AMD, Diabetes Retinopathy or Retinitis Pigmentosa. By full sight we mean the patient will be able to watch TV and identify faces,” said
Ra’anan Gefen, managing director of Nano Retina: “We have a working ‘electrical’ prototype and have demonstrated proof of concept. We intend to use the generous funding from BIRD to miniaturize the system and develop a ‘nano’ prototype. All of the medical and technology industry experts with whom we have consulted agree that our product develop- ment expectations are attainable. We have laid the development foundation and now expect to begin clinical trials in 2012.”
http://www.nano-retina.com http://www.rainbowmedical.co.il http://www.zyvexlabs.com
N N
anosphere, Inc. (NASDAQ: NSPH) announced that it intends to offer shares of its common
stock in a public offering.
http://www.nanosphere.us
anoString Technologies, Inc., a privately held life sciences company marketing a comple- te solution for detecting and counting large sets of
10-04 :: April 2010
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87